CMR Substudy of Coronary Sinus Reducer for the Management of Symptomatic Heart Failure With a Preserved Ejection Fraction (HFpEF) Associated With Coronary Microvascular Dysfunction (CMD)
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥18
• Enrollment in main CS-reducer HFPEF study IRB# 25-002292
Locations
United States
Minnesota
Mayo Clinic
RECRUITING
Rochester
Contact Information
Primary
Diana Albers
albers.diana2@mayo.edu
507-255-6884
Time Frame
Start Date: 2025-10
Estimated Completion Date: 2027-08
Participants
Target number of participants: 25
Treatments
Heart Failure with a Preserved Ejection Fraction (HFpEF)
Subjects with diagnosed Heart failure with a preserved ejection fraction (HFpEF), non-obstructive Coronary Artery Disease (CAD), and have documented CMD.
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic